Free Trial

Solaris Resources (SLS) Competitors

Solaris Resources logo
C$5.84 -0.31 (-5.04%)
As of 03:29 PM Eastern

SLS vs. AUP, BHC, CARA, CRON, TEV, ABT, NOT, PYR, NVO, and DNA

Should you be buying Solaris Resources stock or one of its competitors? The main competitors of Solaris Resources include Aurinia Pharmaceuticals (AUP), Bausch Health Companies (BHC), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

Solaris Resources vs.

Solaris Resources (TSE:SLS) and Aurinia Pharmaceuticals (TSE:AUP) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

In the previous week, Solaris Resources had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Aurinia Pharmaceuticals. Solaris Resources' average media sentiment score of 0.00 equaled Aurinia Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Solaris Resources Neutral
Aurinia Pharmaceuticals Neutral

Aurinia Pharmaceuticals' return on equity of 0.00% beat Solaris Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A -438.08% -51.67%
Aurinia Pharmaceuticals N/A N/A N/A

25.1% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Solaris Resources currently has a consensus target price of C$13.90, indicating a potential upside of 138.01%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Solaris Resources has higher earnings, but lower revenue than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.57-10.17
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A

Aurinia Pharmaceuticals received 232 more outperform votes than Solaris Resources when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 50.00% of users gave Solaris Resources an outperform vote.

CompanyUnderperformOutperform
Solaris ResourcesOutperform Votes
15
50.00%
Underperform Votes
15
50.00%
Aurinia PharmaceuticalsOutperform Votes
247
72.22%
Underperform Votes
95
27.78%

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 9 of the 14 factors compared between the two stocks.

Get Solaris Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLS vs. The Competition

MetricSolaris ResourcesOther Precious Metals & Mining IndustryMaterials SectorTSE Exchange
Market CapC$669.93MC$250.64MC$3.02BC$5.68B
Dividend YieldN/A6.06%5.18%6.84%
P/E Ratio-10.1710.9375.6928.71
Price / SalesN/A9,734,795.4424,272,056,611,889,800.00610.17
Price / Cash64.5313.1024.3283.20
Price / Book60.339.585.153.72
Net Income-C$46.49M-C$2.74MC$155.11MC$301.04M
7 Day Performance1.21%-2.04%-0.32%0.33%
1 Month Performance28.35%-1.94%1.82%-0.17%
1 Year Performance13.62%23.89%16.72%14.10%

Solaris Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLS
Solaris Resources
1.7768 of 5 stars
C$5.84
-5.0%
C$13.90
+138.0%
+20.6%C$669.93MN/A-10.1710News Coverage
Gap Up
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
BHC
Bausch Health Companies
N/AC$7.60
+1.5%
N/A-39.2%C$1.98BC$6.69B-11.1219,900
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
CRON
Cronos Group
1.1538 of 5 stars
C$2.55
+0.4%
C$3.54
+38.8%
-36.0%C$673.37MC$76.86M-14.19450
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640

Related Companies and Tools


This page (TSE:SLS) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners